Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...

With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

A highly effective class of weight loss drug has taken the world by storm, as medications like Ozempic, Wegovy, and Zepbound ...

FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

The FDA has decided to reconsider its previous decision that barred drug compounders from selling their versions of Eli Lilly ...